High levels of serum glycans monovalent IgG immune complexes detected by dissociative ELISA in experimental visceral leishmaniasis

Autor(es)

de Carvalho, Camila Aparecida ^[1] ; Ferrao, Thiago Fidelis ^[1] ; Novais de Freitas, Flavia Regina ^[1] ; de Andrade Junior, Heitor Franco ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Lab Protozool, Inst Med Trop, Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: IMMUNOLOGY; v. 158, n. 4, p. 314-321, DEC 2019.
• Citações Web of Science: 0

Resumo

Visceral leishmaniasis (VL) is epidemic in Brazil with an increasing incidence of human cases and canine reservoirs, with host hypergammaglobulinemia. Conventional enzyme-linked immunosorbent assay (cELISA) based on several parasitic antigens is the main method for diagnosis and indication of treatment. Dissociative ELISA (dELISA) uses acidic treatment to free immunoglobulin G (IgG) from immune complexes, and its use revealed a significant positive fraction of suspected cases with negative serology. Looking for small molecules or haptens that block IgG antibodies, we purified by molecular exclusion chromatography, 1000-3000 MW molecules from promastigote soluble extract, mostly oligosaccharides comprising 6-13 sugar residues using MALDI-TOF analysis. Glycan-BSA complex (GBC) was constructed by conjugating promastigote glycans to BSA molecules, allowing their use in the solid support in cELISA or dELISA. Sera from experimentally infected hamsters showed higher levels of blocked monomeric IgG during infection, mostly against GBC, which was also present in lower concentrations in the promastigote soluble extract dELISA. Those data show that most of the specific monomeric IgG in serum are blocked by haptens composed by glycans produced by the parasite, better detected in the high dilution of sera in the dELISA assays. dELISA is a useful technique for detecting blocked monomeric antibodies that could have difficult clearance from blood, which could result in hypergammaglobulinemia. (AU)

• Processo FAPESP: 17/26558-9 - Haptenos na leishmaniose visceral. Desenvolvimento de ensaios de fase sólida para diagnóstico e sua imunologia em modelos experimentais.
• Beneficiário: Heitor Franco de Andrade Junior
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/50218-2 - CEPEMA - Centro Cooperativo em Engenharia Ambiental
• Beneficiário: Claudio Augusto Oller do Nascimento
• Modalidade de apoio: Auxílio à Pesquisa - Temático